drugset / Trial / NCT04518163

Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa

NCT04518163 ↗

Unknown 140 enrolled Aswan University Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Objective to investigate the effect of adjunctive intravenous tranexamic acid (TA) on blood loss during cesarean section (CS) in patients with placenta previa undergone Bakri balloon tamponade

Timeline

Start
2020-09-01
Primary completion
2022-06-30
Completion
2022-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications